Egypt-based healthtech startup Otida has raised $340,000 in a pre-Seed round led by Lofty Inc, a US-based VC, with participation from Flat6Labs Cairo, Afropreneurs, Jedar Capital, OQAL Angel Investors, UI Investments, and a group of angel investors.
Founded in 2021 by Ahmed Tawfic and Ayman Mostafa, Otida, formerly “instadiet”, is designed to help diabetic patients maintain a healthy lifestyle and make informed choices concerning nutrition and exercise.
The startup aims to use the funds to expand its digital diabetes treatment across Egypt and the wider Mena region.
Ahmed Tawfic, founder and CEO of Otida said, “Otida’s business model revolves around the needs of patients with diabetes. We believe that with the level of technology we are surrounded by today, it’s unacceptable to have patients with diabetes still struggling to find the right treatment program that fits each individual condition.”
Otida collects a minimum of 100 data points, per patient, per day, to tailor the best-personalized care model for each user on the app. Otida’s solution is a care model that is rooted in technology, it adopts the most up-to-date guidelines to present the most effective care model. Once signed up for Otida, patients receive wearables to read blood sugar levels every 15 minutes and report back to the cloud without having to have the patients prick their fingers with an archaic blood sugar monitor. That is in addition to the data collected from the patients, such as food consumed, the medication prescribed, and periodical lab tests. That way, and to return with the best fitting care model, the app learns a lot about the patient’s nutrition, glycemic responses to different food and medications, their lifestyle, and behavior.
Each patient gets assigned a coach who is available around the clock. Otida also educates its patients about their conditions and how they can measure their insulin and blood levels and how they can use that data to improve their lifestyles.
The Otida tech solution has changed many lives. Thanks to smart technology and sharp data analytics, Otida has been able to reverse diabetes for those diagnosed with type 2.
Mona AbdelMoteleb, Medical Director of Otida said, “We have patients with type 2 diabetes who were insulin-dependent, with Otida’s guidance they stopped taking it and stopped depending on medications altogether. We want to be a companion to help diabetic patients live a normal, happy life.” Today, the Otida team is composed of eight members all working towards one mission: to make the life of each user with diabetes easier. To expand Otida’s footprint to a milestone of 5,000
